Development of a sensitive LC-MS/MS method for the determination of bilobalide in rat plasma with special consideration of ex vivo bilobalide stability: application to a preclinical pharmacokinetic study.

[1]  V. Gottifredi,et al.  The Sesquiterpene Lactone Dehydroleucodine Triggers Senescence and Apoptosis in Association with Accumulation of DNA Damage Markers , 2013, PloS one.

[2]  Dan S. Tawfik,et al.  Catalytic versatility and backups in enzyme active sites: the case of serum paraoxonase 1. , 2012, Journal of molecular biology.

[3]  P. Solich,et al.  Determination of pravastatin and pravastatin lactone in rat plasma and urine using UHPLC-MS/MS and microextraction by packed sorbent. , 2012, Talanta.

[4]  J. Hartmann,et al.  Neuroprotective effects of bilobalide are accompanied by a reduction of ischemia-induced glutamate release in vivo , 2011, Brain Research.

[5]  T. Fukami,et al.  Human Paraoxonase 1 Is the Enzyme Responsible for Pilocarpine Hydrolysis , 2011, Drug Metabolism and Disposition.

[6]  S. Doré,et al.  Heme oxygenase 1, beneficial role in permanent ischemic stroke and in Gingko biloba (EGb 761) neuroprotection , 2011, Neuroscience.

[7]  Fulin,et al.  Bilobalide inhibits the expression of aquaporin 1, 4 and glial fibrillary acidic protein in rat brain tissue after permanent focal cerebral ischemia , 2011 .

[8]  H. Gali-Muhtasib,et al.  What made sesquiterpene lactones reach cancer clinical trials? , 2010, Drug discovery today.

[9]  Huaiqin Wu,et al.  High-throughput salting-out assisted liquid/liquid extraction with acetonitrile for the simultaneous determination of simvastatin and simvastatin acid in human plasma with liquid chromatography. , 2010, Analytica chimica acta.

[10]  A. Riva,et al.  Liquid chromatography/atmospheric pressure chemical ionization ion trap mass spectrometry of bilobalide in plasma and brain of rats after oral administration of its phospholipidic complex. , 2009, Journal of pharmaceutical and biomedical analysis.

[11]  K. Kuwayama,et al.  In vitro stability and metabolism of salvinorin A in rat plasma , 2009, Xenobiotica; the fate of foreign compounds in biological systems.

[12]  T. V. van Beek,et al.  Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals. , 2009, Journal of chromatography. A.

[13]  P. Solich,et al.  HPLC methods for the determination of simvastatin and atorvastatin , 2008 .

[14]  J. Hartmann,et al.  Role of glycine receptors and glycine release for the neuroprotective activity of bilobalide , 2008, Brain Research.

[15]  Zhen Zhou,et al.  Simultaneous determination of ginkgolides A, B, C and bilobalide in plasma by LC-MS/MS and its application to the pharmacokinetic study of Ginkgo biloba extract in rats. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[16]  Y. L. Loukas,et al.  An improved and fully validated LC-MS/MS method for the simultaneous quantification of simvastatin and simvastatin acid in human plasma. , 2008, Journal of pharmaceutical and biomedical analysis.

[17]  Chuan Li,et al.  Simultaneous determination of ginkgo flavonoids and terpenoids in plasma: Ammonium formate in LC mobile phase enhancing electrospray ionization efficiency and capacity , 2008, Journal of the American Society for Mass Spectrometry.

[18]  N. Lopes,et al.  A new high-performance liquid chromatography assay for the determination of sesquiterpene lactone 15-deoxygoyazensolide in rat plasma. , 2007, Analytica chimica acta.

[19]  V. Stella,et al.  A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor. , 2007, Journal of pharmaceutical sciences.

[20]  V. Kumar,et al.  Bilobalide prevents ischemia-induced edema formation in vitro and in vivo , 2007, Neuroscience.

[21]  A. Riva,et al.  LC-MS characterization of terpene lactones in plasma of experimental animals treated with Ginkgo biloba extracts Correlation with pharmacological activity. , 2006, Journal of pharmaceutical and biomedical analysis.

[22]  Jin Sun,et al.  LC-ESI-MS Determination of Bilobalide and Ginkgolides in Canine Plasma , 2006 .

[23]  Y. Machida,et al.  Stability of spironolactone in rat plasma: strict temperature control of blood and plasma samples is required in rat pharmacokinetic studies. , 2005, Biological & pharmaceutical bulletin.

[24]  Hui Wang,et al.  Preclinical pharmacology of 2-methoxyantimycin A compounds as novel antitumor agents , 2005, Cancer Chemotherapy and Pharmacology.

[25]  B. Lynn,et al.  Degradation of camptothecin-20(S)-glycinate ester prodrug under physiological conditions. , 2004, Journal of pharmaceutical and biomedical analysis.

[26]  Duane D. Miller,et al.  Favorable effects of weak acids on negative-ion electrospray ionization mass spectrometry. , 2004, Analytical chemistry.

[27]  P. Mauri,et al.  Liquid chromatography/atmospheric pressure chemical ionization ion trap mass spectrometry of terpene lactones in plasma of animals. , 2003, Journal of pharmaceutical and biomedical analysis.

[28]  F. V. Defeudis,et al.  Bilobalide and neuroprotection. , 2002, Pharmacological research.

[29]  C. Gardana,et al.  Liquid chromatography/atmospheric pressure chemical ionization mass spectrometry of terpene lactones in plasma of volunteers dosed with Ginkgo biloba L. extracts. , 2001, Rapid communications in mass spectrometry : RCM.

[30]  C. Enke,et al.  Practical implications of some recent studies in electrospray ionization fundamentals. , 2001, Mass spectrometry reviews.

[31]  C Watson,et al.  Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[32]  L. Zhou,et al.  Reactive oxygen species-induced apoptosis in PC12 cells and protective effect of bilobalide. , 2000, The Journal of pharmacology and experimental therapeutics.

[33]  Yuan-qing Xia,et al.  Bioanalytical method validation design for the simultaneous quantitation of analytes that may undergo interconversion during analysis. , 2000, Journal of pharmaceutical and biomedical analysis.

[34]  E. Koch,et al.  Bioavailability of Ginkgolides and Bilobalide from Extracts of Ginkgo biloba using GC/MS , 1999, Planta medica.

[35]  J. Robert,et al.  Kinetics of the in vivo interconversion of the carboxylate and lactone forms of irinotecan (CPT-11) and of its metabolite SN-38 in patients. , 1994, Cancer research.

[36]  D. Bindra,et al.  Urinary and biliary disposition of the lactone and carboxylate forms of 20(S)-camptothecin in rats. , 1994, Drug metabolism and disposition: the biological fate of chemicals.